Christopher Yasenchak, M.D.

Christopher Yasenchak, M.D.
Hematology-Oncology · Eugene, OR

Christopher Yasenchak, M.D. is a hematology-oncology in Eugene, OR with about 27 yrs in practice.

  • SpecialtyHematology-Oncology
  • Medical schoolPENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE (1999)
  • TelehealthOffers telehealth visits
  • Practice size48 clinicians
  • Medicare assignmentAccepts assignment (Medicare-approved amount as full payment)
  • Medicare activity~610 patients across 6,957 services, avg age 74

Common services

ServiceMedicare servicesMedicare allows
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count893$8See prices →
Blood test, comprehensive group of blood chemicals865$10See prices →
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more483$124See prices →
Lactate dehydrogenase (enzyme) level393$6See prices →
Administration of chemotherapy into vein, 1 hour or less332$127See prices →
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more236$89See prices →
Administration of chemotherapy into vein, each additional hour101$27See prices →
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less100$61See prices →
Ferritin (blood protein) level79$13See prices →
Iron level70$6See prices →
Complete blood cell count (red cells, white blood cell, platelets), automated test69$6See prices →
Uric acid level, blood47$4See prices →

Hospital affiliations

Source: CMS Medicare Physician & Other Practitioners and the Doctors & Clinicians National Downloadable File (most recent release). Counts reflect Original Medicare activity only and are not a measure of quality. “Medicare allows” is the Medicare fee schedule amount — not what an insured or cash patient pays; for patient prices see the linked procedure pages. Always confirm a clinician’s current details with their office.